Chemotherapy of mammary carcinomas arising in ras transgenic mice
β Scribed by Daniel L. Dexter; Melody Diamond; Janet Creveling; Shih-Fong Chen
- Book ID
- 104986193
- Publisher
- Springer US
- Year
- 1993
- Tongue
- English
- Weight
- 593 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0167-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Transgenic WAPRAS mice, obtained by infection of the construct WAP promoter murine gene and the HRAS human protooncogene, develop mammary adenocarcinoma within 1-3 months after pregnancy. A cytogenetic analysis was performed on I 7 tumors from I0 mice. Almost all detected anomalies were chromosome g
FVBN202 mice, which are transgenic for the rat neu gene, spontaneously develop mammary carcinomas between 6 and 7 months of age. We investigated whether these spontaneous tumors (spontaneous breast carcinoma cells, SBCC) could elicit an immune response in naive 6-to 8-week-old FVBN202 transgenic and
A prominent phenotype of plasmin deficiency in mice is reduced metastasis in the MMTV-PymT transgenic breast cancer model. Proteolytically active plasmin is generated from inactive plasminogen by one of 2 activators, uPA or tPA. We now find that uPA deficiency alone significantly reduces metastasis